Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab

INTRODUCTION: Advanced urachal carcinoma has a poor prognosis; however, a standard systemic treatment has not been established. We treated a patient with relapsed urachal carcinoma with capecitabine‐oxaliplatin plus bevacizumab, a standard regimen for colon cancer, and obtained favorable responses....

Descripción completa

Detalles Bibliográficos
Autores principales: Hatano, Akihiko, Wakaki, Kunihiko, Miyajima, Norio, Komatsu, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622206/
https://www.ncbi.nlm.nih.gov/pubmed/37928300
http://dx.doi.org/10.1002/iju5.12619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622206/
https://www.ncbi.nlm.nih.gov/pubmed/37928300
http://dx.doi.org/10.1002/iju5.12619

Ejemplares similares